Optune Gio News Today

NovoCure Limited (NASDAQ:NVCR – Get Free Report) Director W Anthony Vernon sold 964 shares of the business’s stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $23.89, for a total transaction of $23,029.96. Following the sale, the director now owns 164,833 shares of the company’s stock, valued […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) Director W Anthony Vernon sold 964 shares of the business’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $23.89, for a total value of $23,029.96. Following the sale, the director now owns 164,833 shares of the company’s stock, valued […]

Rhenman & Partners Asset Management AB bought a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 160,000 shares of the medical equipment provider’s stock, valued at approximately $2,389,000. Rhenman & Partners Asset Management AB […]

Rhenman & Partners Asset Management AB bought a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 160,000 shares of the medical equipment provider’s stock, valued at approximately $2,389,000. Rhenman & Partners Asset Management AB […]

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares traded down 6.2% during trading on Tuesday . The stock traded as low as $21.64 and last traded at $21.71. 545,541 shares traded hands during trading, a decline of 59% from the average session volume of 1,346,685 shares. The stock had previously closed at $23.15. Analysts Set […]

NVCR earnings call for the period ending March 31, 2024.

BioPharma Credit PLC on Thursday announced a major investment in a Swiss cancer treatment specialist. The London-based investment company, focused on the life sciences sector, has entered into a...

Investegate announcements from NEW INVESTMENT OF UP TO US$400 MILLION

C WorldWide Group Holding A S boosted its stake in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 135.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 521,784 shares of the medical equipment provider’s stock after acquiring an additional 300,000 shares during the period. C WorldWide […]